Biotin-Dependent Carboxylation: The Swinging-Arm CO2 Carrier

What It Is and Where It Happens

Biotin-dependent carboxylation is the enzymatic addition of a carboxyl group (-COO⁻) to an organic substrate, powered by ATP and carried by the vitamin biotin. The whole family shares a modular architecture built from three functional pieces:

• a biotin carboxylase (BC) domain that first activates bicarbonate and carboxylates biotin;
• a carboxyltransferase (CT) domain that hands the carboxyl group to the real substrate;
• a small biotin carboxyl carrier protein (BCCP) domain that holds the biotin on a conserved lysine and physically moves between the other two.

In humans these enzymes live in the mitochondrial matrix (pyruvate carboxylase, propionyl-CoA carboxylase, 3-methylcrotonyl-CoA carboxylase) or the cytosol (acetyl-CoA carboxylase 1). They anchor gluconeogenesis, fatty-acid synthesis, and the catabolism of odd-chain fatty acids and branched-chain amino acids. In plants and bacteria, homologous carboxylases initiate fatty-acid and polyketide biosynthesis, making this one of the most evolutionarily conserved cofactor strategies in biology.

The Mechanism, Step by Step

Every biotin carboxylase runs the same two half-reactions, in two physically separate active sites, linked by the swinging arm:

• Half-reaction 1 (BC site): ATP phosphorylates bicarbonate to form a reactive carboxyphosphate intermediate (O-CO-OPO3). This decomposes to CO2 and Pi within the active site, and the CO2 is attacked by the N1' nitrogen of biotin, producing N1'-carboxybiotin. ATP is spent as ADP + Pi.
• Translocation: The BCCP domain, with carboxybiotin dangling on its ~1.6 nm biotinyl-lysine arm (the "biocytin" tether), swings roughly 7 nm from the BC site to the CT site.
• Half-reaction 2 (CT site): The substrate (e.g., pyruvate) is deprotonated to an enolate/carbanion, which nucleophilically attacks the carboxyl carbon of carboxybiotin. The carboxyl group transfers to the substrate, regenerating free biotin.

Because the two chemistries happen in separate compartments, the reactive carboxybiotin never diffuses into solution—it is shielded on the arm. The net cost is one ATP per CO2 fixed, and the reaction is effectively irreversible under cellular conditions.

Key Molecules and Characteristic Numbers

The cofactor is biotin (vitamin B7), a bicyclic ureido-thiophene ring, MW 244 Da. It is attached through an amide bond between its valeric acid tail and the ε-amino group of a specific lysine in the sequence motif Ala-Met-Lys-Met, forming biocytin. This attachment is made by holocarboxylase synthetase (HLCS), which "biotinylates" all five human carboxylases; the reverse, recycling free biotin from degraded enzymes, is done by biotinidase (BTD).

• Pyruvate carboxylase is an α4 homotetramer, each subunit ~130 kDa, containing all three domains plus a regulatory allosteric site for acetyl-CoA, which is essentially obligatory for activity.
• Propionyl-CoA carboxylase is an α6β6 dodecamer (~750 kDa); the α-subunit (PCCA gene) carries biotin, the β-subunit (PCCB) does the transfer.
• The biotinyl-lysine arm spans ~1.6 nm; the BC and CT active sites are ~7 nm apart, so the arm plus BCCP-domain motion covers the gap.

Turnover numbers are modest—pyruvate carboxylase runs at roughly 60-100 s⁻¹—reflecting the physical translocation step built into each cycle.

How It Is Studied and Regulated

The mechanism was dissected biochemically before structures existed. Isotope labeling with ¹⁴C-bicarbonate showed the carbon enters via HCO3⁻, not free CO2, and traps carboxybiotin as an acid-labile intermediate. Avidin, the egg-white protein that binds biotin with femtomolar affinity (Kd ≈ 10⁻¹⁵ M), is used to inhibit and quantify these enzymes and to detect biotinylated proteins on blots.

Regulation differs by enzyme:

• Acetyl-CoA carboxylase is the textbook control point of lipogenesis: citrate allosterically activates it (and drives polymerization into active filaments), while palmitoyl-CoA inhibits it, and AMPK phosphorylation switches it off when energy is low.
• Pyruvate carboxylase is switched on by acetyl-CoA, coupling gluconeogenic/anaplerotic flux to fuel status.

Crystal and cryo-EM structures (notably of Rhizobium and Staphylococcus pyruvate carboxylase, ~2008-2011) finally caught the BCCP domain in transit and confirmed that the two active sites of a working enzyme belong to different subunits of the oligomer.

How It Compares to Related Carbon-Fixing Chemistry

Biotin carboxylation is one of several ways life attaches CO2 to carbon skeletons, and contrasting them clarifies its niche:

• vs. RuBisCO (photosynthesis): RuBisCO fixes CO2 into a 5-carbon sugar for net carbon gain using a Mg²⁺-carbamate mechanism, no biotin and no ATP at the fixation step. Biotin carboxylases instead do metabolic carboxylations that are later removed or rearranged, spending ATP each time.
• vs. PEP carboxylase: PEPCase (in C4/CAM plants) fixes bicarbonate onto phosphoenolpyruvate using the energy of PEP's phosphate bond—no biotin, no separate BC/CT sites.
• vs. vitamin-K-dependent (γ-glutamyl) carboxylase: that enzyme carboxylates glutamate residues in clotting factors using vitamin K and O2, a completely different cofactor logic.
• vs. thiamine (TPP) or lipoate swinging arms: like biotin, lipoic acid and the phosphopantetheine of ACP are covalently tethered mobile arms—biotin is the CO2-specialist member of this "swinging-arm" club.

The defining signature of biotin chemistry is the covalent, energy-loaded carboxybiotin intermediate physically shuttled between sites.

Significance, Disease, and Open Questions

Because these enzymes gate gluconeogenesis, lipogenesis, and amino-acid/odd-chain-fat breakdown, their failure produces serious inherited metabolic disease. Pyruvate carboxylase deficiency causes lactic acidosis and neurological damage. Propionic acidemia (PCCA/PCCB mutations) and 3-MCC deficiency are detected on newborn screening. Crucially, defects in the shared biotin-handling enzymes—holocarboxylase synthetase deficiency (neonatal) and biotinidase deficiency (later-onset)—inactivate all five carboxylases at once, producing multiple carboxylase deficiency; many cases respond dramatically to oral biotin supplementation.

The family is also a drug target: acetyl-CoA carboxylase inhibitors are pursued for metabolic disease, cancer, and as antibiotics/herbicides (plant ACC is the target of "fop" and "dim" herbicides). Open questions include exactly how the BCCP arm is timed so carboxybiotin is protected from wasteful decarboxylation, how ACC's citrate-driven polymerization is dynamically tuned in cells, and whether allosteric pockets can be exploited for tissue-selective therapeutics.

Major biotin-dependent carboxylases in human and microbial metabolism

Enzyme	Substrate → Product	Pathway role	Notable feature
Pyruvate carboxylase (PC)	Pyruvate → oxaloacetate	Gluconeogenesis, anaplerosis	Mitochondrial; activated by acetyl-CoA; ~130 kDa, α4 homotetramer
Acetyl-CoA carboxylase (ACC)	Acetyl-CoA → malonyl-CoA	Committed step of fatty-acid synthesis	Rate-limiting; regulated by citrate, AMPK phosphorylation, polymerization
Propionyl-CoA carboxylase (PCC)	Propionyl-CoA → D-methylmalonyl-CoA	Odd-chain fatty-acid & branched amino-acid catabolism	α6β6 dodecamer; defects cause propionic acidemia
3-Methylcrotonyl-CoA carboxylase (MCC)	3-MC-CoA → 3-methylglutaconyl-CoA	Leucine degradation	Defects cause 3-MCC deficiency (common on newborn screens)
Urea carboxylase / others	Urea → allophanate	Nitrogen recycling (fungi, bacteria)	Illustrates the family's spread beyond central metabolism